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Clinicopathologic study of resected, peripheral, small-sized lung 
cancer tumors, 1 cm or less in diameter, and their long-term results 
after surgery 
Togashi, Ken-Ichi 
Nagaoka Red Cross Hospital, Nagaoka-shi, Japan
Objective: The number of interventions for very small-sized lung 
cancer has increased with the development of computed tomography 
for medical checkup. We attempted to identify the clinicopathologic 
characteristics of peripheral, very small-sized lung cancer and their 
long-term results after surgery. 
Methods: A retrospective analysis of 1245 patients who underwent 
complete resection for lung cancer between 1981 and 2004 in our hos-
pital was performed. Sixty-two patients (5%) had tumors 1 cm or less 
in diameter (Group S) and 217 patients (17%) had tumors 1 to 2 cm in 
diameter (Group L). The probability of survival was calculated using 
the Kaplan-Meier method. 
Results: All diseases were detected by medical checkup in both 
groups. 53% of Group S patients and 31% of Group L patients were 
not diagnosed deﬁnitively with lung cancer before surgery. In Group 
S, preoperative deﬁnitive diagnosis was obtained by CT-guided needle 
biopsy for 22 patients or by transbronchial lung biopsy for seven pa-
tients. The histologic type of adenocarcinoma was found in 49 patients 
(79%) in Group S and 173 patients (80%) in Group L. Other histo-
logic types included squamous cell carcinoma, large cell carcinoma, 
small cell carcinoma, carcinoid, and others in both groups. Fifty-seven 
patients (92%) in Group S and 165 patients (76%) in Group L showed 
pathologic stage IA. In Group S, the other stages were two IB, one IIA, 
and two IIIB. There were 14 bronchioloalveolar carcinomas (26% of 
IA diseases) in Group S and 22 (13% of IA diseases) in Group L. The 
5-year survival rates of IA patients were 90% in Group S and 80% in 
Group L. The 5-year survival rate of 36 bronchioloalveolar carcino-
mas in both Groups S and L was 94%. The 5-year survival rate of the 
patients with tumors 2 cm or less in diameter (Group S + L) was 86% 
after lobectomy or pneumonectomy, and 77% after wedge resection or 
segmentectomy, while the 5-year survival rate of patients with tumors 
1cm or less in diameter (Group S) was only 91% after lobectomy or 
pneumonectomy, and 90% after wedge resection or segmentectomy. 
Postoperative deaths from various causes were four in Group S and 28 
in Group L, but deaths from cancer recurrence were one in Group S and 
10 in Group L. There were no deaths in patients with bronchioloalveo-
lar carcinoma.
Conclusion: Patients in Group S showed better prognosis than those 
in Group L, and their 5-year survival rate was good following partial 
resection or segmentectomy as well as lobectomy or pneumonectomy, 
therefore, we might deﬁne peripheral, small-sized lung cancer tumor of 
1 cm or less in diameter as peripheral early cancer. The further spread 
of computed tomographic screening is essential for the early detec-
tion of peripheral, small-sized lung cancer tumors of 1 cm or less in 
diameter.
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Background: It is important to understand the present characteris-
tics of lung cancer patients. However, it is difﬁcult to obtain updated 
information regarding lung cancer surgery. Since 2001, Niigata Chest 
Surgery Study Group has begun registration of lung cancer surgery to 
determine statistics regarding lung cancer surgery underwent in Niigata 
Prefecture. Here we summarize the clinico-pathological features of 
3306 resected lung cancer performed during 5 years. 
Method: We registered patients who underwent surgical resection for 
only primary lung cancer. 
A total 31 medical data for each patient were registered. Registra-
tion was by mail to the data center after the histological diagnosis and 
pathologic features were known.
Result: A total of 3306 patients were registered in Niigata Prefecture 
in 5 year periods. A total of 1650 (50%) cases were detected by mass 
screening, only 14 % patients were symptomatic, and 35% patients 
were detected during other diseases. With spread of lung cancer 
screening using computed tomography, increasing number of small and 
cloudy nodules have been detected. In 64% cases, diagnosis of lung 
cancer was established by brochoscopy and percutaneous lung biopsy. 
2129 cases (64 %) were diagnosed as lung cancer preoperatively. The 
2169 males and 1137 females had a mean age of 68.1 years. The peak 
age was 70’s followed by 60’s. In most cases, clinical stage was evalu-
ated by chest and abdominal computed tomography, brain magnetic 
resonance imaging, and bone schintigraphy.
Mean tumor diameter was 3.0 cm. 60% patients were diagnosed as hav-
ing T1 tumor and over 80% patients did not have lymph node metasta-
sis. 85% patients were diagnosed as clinical stage I.
There were 1963 c-stage IA cases (59%) and 863 c-stage IB cases 
(26%). The most common operative procedure was single lobectomy 
in 2266 cases (69 %), followed by wedge resection in 469 cases (14 
%), segmental resection in 325 cases (10%). Pneumonectomy was 
performed in only 50 cases (1.5%). The tumor was histologically clas-
siﬁed as adenocarcinoma in 70.5% patients, squamous cell carcinoma 
in 22.6%.
According to the pathological classiﬁcation, 53% patients were stage 
IA, 21% were stage IB.
Therefore 73 % patients were classiﬁed as pathological stage I. Post-
operative complications were also reported in our registry. Complica-
tion was deﬁned as any events that required unscheduled treatments. 
There was 425 caompications out of 2569 cases during 4 years. Air 
leakage was the most common complication followed by pnuemonia, 
arrythmia, and respiratory failure. Complications increased as patient’ 
age increases. The age of the patients who developed complications 
was signiﬁcantly higher than that of the patients without complica-
tions. Multivarient analysis revealed that male, high age, and patients 
detected during other disease are signiﬁcant factors for developing 
complication. Operative mortality in our registry was 0.9% and was 
less than that from national registry.
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Summary: This study illustrates that a higher ratio of surgical treated 
stage I patients in Niigata Prefecture. Adenocarcinoma was the most 
frequent histology. These updated data may predict future strategy for 
preventing and treating lung cancer. Follow-up study to determine the 
5-year survival should be scheduled.
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Patients with cancer have an increased risk of thromboembolism which 
leads to additional morbidity and mortality, also reduces the quality of 
life. Hypercoagulation is the most important cause of thromboembo-
lism in malignancy. Extended immobilization, operations and executed 
chemotherapy are the other risk factors for thromboembolism in cancer 
patients. 
202 patients had been hospitalized in our clinic with the diagnosis of 
malignancy in 2006; 188 patients had the diagnosis of lung cancer in 
this group. The patients who had the complaints like sudden dyspnea, 
tachypnea, chest pain were evaluated for pulmonary thromboembo-
lism when venous thrombosis was investigated if there were physical 
ﬁndings such as swelling, pain, erythema and warmth of extremities. 
The investigated patients with the possible diagnosis of thromboem-
bolism did not have any other risk factors for this disease; the only 
risk factor was malignancy. Spiral computed tomography or venous 
Doppler ultrasonography were performed to demonstrate thromboem-
bolism at these patients. Thrombosis or embolism were determined in 
34 of all cancer patients (16.8 %) when the number of new diagnosis 
of thromboembolism was 27 in 188 lung cancer patients (14.4 %). The 
mean age was 62,1 and thromboembolism was found in 23 men (67.7 
%) and 11 women (32.3 %). In the patients with lung cancer, there were 
12 patients with pulmonary thromboembolism, 8 with venous thrombo-
sis, 6 with superior vena cava syndrome and one patient with brachial 
artery embolism. All of the lung cancer patients with thromboembolism 
had NSCLC; 11 of them had adenocarcinoma, 5 had squamous cell 
lung carcinoma and in 11 patients, there was no certain histopathologi-
cal type of NSCLC. There were 85 patients who had the diagnosis of 
thromboembolism in our clinic in 2006; malignancy was the only main 
risk factor for VTE in 34 patients (40 %) and the existence of lung 
cancer was 31.7 % in all thromboembolism patients.
Malignancy, mostly the lung cancer, is one of the most important 
acquired medical predispositions for thromboembolism. Furthermore, 
it should not be forgotten that thromboembolism is seen with a high 
frequency in lung cancer patients.
P3-270 NSCLC: Surgery Posters, Wed, Sept 5 – Thur, Sept 6 
An analysis of surgical skills in pleuro-pneumonectomy of lung 
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To evaluate the surgical skills in pleuro-pneumonectomy of lung 
cancer with effusion and the effect of the operation, from Jan.1988 
to Jan.2003, 21 patients of primary lung cancer with dissemination 
and malignant pleural effusion were treated chieﬂy by operation. The 
surgical procedures included left pleuro-pneumonectomy in 8 and right 
pleuro-pneumonectomy in 13 patients. The operative skills include 
plural dissection en bloc, management of big vessel in hilar, paying 
attention to disposal of dissemination on pericardium, big vessels and 
diaphragm, etc. All patients recovered postoperatively. There were no 
severe surgical complications such as bronchopleural ﬁstula, empyema 
and hemorrhage. Follow-up showed that 16 patients have died at 5 to 
34 months after the operation. Other patients were still alive at 24 to 29 
months. Mid-lifetime was 18 months. Pleuro-pneumonectomy selec-
tively performed in lung cancer with malignant pleural effusion (IIIb) is 
safe and manipulatable. Improvement of the surgical skills may reduce 
the perioperative complications, decrease recurrence of the tumor and 
so gain a better result.
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Objectives: The incidence of lung cancer associated with interstitial 
pneumonia (IP) is higher than that of general population. However, 
treatment of that cancer is difﬁcult because of the risk of acute exacer-
bation of IP. We studied safety and efﬁcacy of surgical treatment in 10 
cases of IP associated lung cancers.
Patients and methods: Ten cases of IP associated lung cancers were 
selected from the 462 cases that underwent surgical operation for pri-
mary lung cancer from 1999 to 2006. Incidence of IP associated cancer 
was 2.16%. All patients were male and average age was 70.5 years 
old (range 56 to 80 years old). Histo-pathological diagnosis of IP was 
UIP (Usual Interstitial Pneumonia) in eight cases and f-NSIP (Fibrotic 
Nonspeciﬁc Interstitial Pneumonia) in two cases.
Result: Lobectomy was performed in seven cases. Six of them 
underwent standard radical lobectomy with mediastinal lymph node 
dissection. Procedures were reduced to segmentectomy in two cases 
and not successful in one case. Histological diagnosis was squamous 
cell carcinoma in 9 cases except one patient who was diagnosed as 
unclassiﬁed carcinoma. Acute exacerbation of IP was observed in only 
one case. The other patients discharged well without any complications. 
Acute exacerbation of IP was responded well to steroid pulse therapy 
and improved. Median survival time of the studied cases was 17.6 
months. Three cases died from exacerbation of interstitial pneumonia, 
and another two cases are still alive. No cancer death was observed in 
the six cases with radical lobectomy group.
Conclusions: Survival outcome of IP associated lung cancer was not 
good. But there was no surgery-associated death and acute exacerbation 
of IP was controllable. Surgical treatment was acceptable and feasible 
therapy for the patients with IP associated lung cancer.
